breast cancer

Image courtesy of the UVA Center for Survey Research


Most women don't know that having dense breasts increases their risk for breast cancer and reduces a mammogram's ability to detect cancer, according to a University of Virginia School of Medicine study.

A random phone survey of 1,024 Virginia women ages 35 to 70, conducted by the UVA Center for Survey Research, found that just 1 in 8 women were aware that breast density is a risk factor for breast cancer, while just 1 in 5 women knew that dense breasts reduced the sensitivity of mammograms to find tumors.

"It is important for women to know whether or not their own breast density is classified into one of the two high-density categories since this will increase their breast cancer risk," said study co-author Wendy Cohn, Ph.D., an associate professor in UVA's Department of Public Health Sciences. "Women need to know whether their breast density will make it harder to detect breast cancer so that, along with their healthcare team, they can consider other options for screening and detection."

Virginia is among at least 27 states that require radiologists to tell women about their breast density, according to the study, and providing that information improves women's understanding of how breast density may impact their health.

The survey found that the strongest factor in knowing about breast density and its relationship with breast cancer was whether a healthcare provider had informed a woman about the density of her breasts. UVA researchers stressed the importance of a conversation between patients and healthcare providers about the impact of breast density.

"The most important thing that doctors and patients can take away from this study is that the required written notice about breast density isn't enough in itself: patients need to talk with their providers about what breast density means for each woman's individual breast cancer risk," said Thomas Guterbock, a professor of sociology and director of the UVA Center for Survey Research.

The study has been published in the Journal of the American College of Radiology. The paper was authored by Guterbock, Cohn, Deborah L. Rexrode, Casey M. Eggleston, Melissa Dean-McKinney, Wendy M. Novicoff, William A. Knaus and Jennifer A. Harvey from UVA, along with Martin J. Yaffe from Sunnybrook Research Institute in Toronto.

For more information: www.news.virginia.edu


Related Content

News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now